Loading interface...

Trajenta 5 mg Tablet

Manufactured byBoehringer Ingelheim India Pvt. Ltd.
ContainsLinagliptin
Description

Trajenta 5 mg Tablet is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adult patients. Patients are advised to follow a strict diet and exercise regimen along with this medicine for the best possible effect. This medicine is not recommended for use in patients with type 1 diabetes and diabetic ketoacidosis.

Substitutes

List of substitutes for Trajenta 5 mg Tablet

Ondero 5 mg Tablet
Lupin Ltd.

Side effects

Major & minor side effects for Trajenta 5 mg Tablet

  • Anxiety
  • Blurred vision
  • Confusion
  • Depression
  • Fast heartbeat
  • Headache
  • Nausea
  • Increased hunger
  • Slurred speech
  • Chills
  • Unusual tiredness or weakness

Uses of Trajenta 5 mg Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to linagliptin or any other inactive ingredients present along with it.

Type 1 Diabetes mellitus

This medicine is not recommended for use in patients with type 1 diabetes mellitus since it is not effective in treating this condition.

Diabetic ketoacidosis

This medicine is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings

Insulin secreagogues

This medicine should be used with caution in patients who are using insulin secretagogues due to the increased risk of hypoglycemia. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition.

Bullous pemphigoid

This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Arthralgia

This medicine should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient's condition. Close monitoring of patient's condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Type 1 diabetes mellitus

This medicine is not recommended for use in patients with a known history of type 1 diabetes mellitus since it is not effective in treating this condition.

Use in pediatrics

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Aripiprazole

Clozapine

Dexamethasone

Dopamine

Acetazolamide

Gatifloxacin

Bexarotene

Disease interactions

Pancreatitis

This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as instructed by the doctor. It can be taken with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Trajenta 5 mg Tablet increases insulin and lowers glucagon production. This results in a reduction of the blood glucose levels.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Dipeptidyl peptidase 4 inhibitors

Schedule

Schedule H

Linagliptin - DrugBank [Internet]. Drugbank.ca. 2017 [cited 18 October 2017]. Available from:

https://www.drugbank.ca/drugs/DB08882

Linagliptin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 18 October 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a611036.html

[Internet]. 2017 [cited 18 October 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.25001.latest.pdf

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 18 October 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

[Internet]. Toxnet.nlm.nih.gov. 2017 [cited 18 October 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2

[Internet]. 2017 [cited 18 October 2017]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201280lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 May 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.